quinuclidines has been researched along with Lymphoma in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 5 (83.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adachi, K; Ikejiri, F; Inoue, M; Ito, S; Jo, Y; Kawakami, K; Kumanomido, S; Miyake, T; Okada, T; Okada, Y; Onishi, C; Suzuki, R; Suzumiya, J; Takahashi, F; Takahashi, T | 1 |
Afreen, S; Erlacher, M; Häcker, G; Manzl, C; Schuler, F; Villunger, A | 1 |
Abhyankar, S; Aljitawi, OS; Deauna-Limayo, D; Ganguly, S; McGuirk, JP; Wick, JA | 1 |
Blackwood, L; Cripps, P; Elliott, J; Grant, IA; Mason, SL | 1 |
Gomyo, H; Goto, H; Imamura, Y; Inui, Y; Ito, M; Kakiuchi, S; Kawamoto, S; Kitagawa, K; Kurata, K; Matsuoka, H; Minami, H; Minami, Y; Miyata, Y; Mizuno, I; Mizutani, Y; Murayama, T; Nomura, T; Sanada, Y; Sugimoto, T; Tominaga, R; Yakushijin, K; Yamamoto, K | 1 |
Barzal, J; Mlot, B; Oborska, S; Pielichowski, W; Rzepecki, P | 1 |
3 trial(s) available for quinuclidines and Lymphoma
Article | Year |
---|---|
A prospective study of palonosetron for prevention of chemotherapy-induced nausea and vomiting in malignant lymphoma patients following highly emetogenic chemotherapy.
Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Isoquinolines; Lymphoma; Male; Middle Aged; Nausea; Palonosetron; Prospective Studies; Quinuclidines; Treatment Outcome; Vomiting | 2018 |
Gastrointestinal toxicity after vincristine or cyclophosphamide administered with or without maropitant in dogs: a prospective randomised controlled study.
Topics: Animals; Antiemetics; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Cyclophosphamide; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Lymphoma; Male; Quinuclidines; Vincristine | 2014 |
A prospective study of the antiemetic effect of palonosetron in malignant lymphoma patients treated with the CHOP regimen.
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Isoquinolines; Japan; Lymphoma; Male; Middle Aged; Nausea; Palonosetron; Prednisolone; Prospective Studies; Quinuclidines; Serotonin Antagonists; Vincristine; Vomiting; Young Adult | 2016 |
3 other study(ies) available for quinuclidines and Lymphoma
Article | Year |
---|---|
Checkpoint kinase 1 is essential for fetal and adult hematopoiesis.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; Benzodiazepinones; Bone Marrow Cells; Cell Line, Tumor; Checkpoint Kinase 1; Embryo, Mammalian; Fetus; G2 Phase Cell Cycle Checkpoints; Hematopoiesis; Hematopoietic Stem Cells; Humans; Lymphoma; Melanoma, Experimental; Mice; Mice, Knockout; Primary Cell Culture; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Pyrazoles; Quinolines; Quinuclidines; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2019 |
Combined use of multiday palonosetron with aprepitant and low-dose dexamethasone in prevention of nausea and emesis among patients with multiple myeloma and lymphoma undergoing autologous hematopoietic stem cell transplant: A pilot study.
Topics: Adult; Aged; Antiemetics; Aprepitant; Dexamethasone; Female; Hematopoietic Stem Cell Transplantation; Humans; Isoquinolines; Lymphoma; Male; Middle Aged; Morpholines; Multiple Myeloma; Nausea; Palonosetron; Pilot Projects; Quality of Life; Quinuclidines; Transplantation, Autologous; Vomiting | 2014 |
Palonosetron in prevention of nausea and vomiting after highly emetogenic chemotherapy before haematopoietic stem cell transplantation-single center experience.
Topics: Antineoplastic Agents; Carmustine; Emetics; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Isoquinolines; Lymphoma; Nausea; Ondansetron; Palonosetron; Quinuclidines; Serotonin Antagonists; Treatment Outcome; Vomiting | 2009 |